Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 1
1(50.0%)
2Total
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04539626Not ApplicableUnknown

Estrogen Therapy in Non-severe COVID-19 Patients

Role: lead

NCT04443270Phase 1Unknown

Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients

Role: lead

NCT03948165Completed

Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention.

Role: lead

NCT03857906Completed

Evaluation of Prophylactic Use of a Preoperative IABP in High-Risk Coronary Artery Bypass Graft Surgery

Role: lead

All 4 trials loaded